ONLINE TDM Methotrexate 09230785190Recalls & reported problems
Roche Diagnostics GmbH · Class U
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 07613336224816), received between Apr 3, 2024 and Apr 21, 2026 — classified as 2 malfunctions.
The most frequently reported specific device problem is “High Test Results” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- High Test Results1
- Incorrect Measurement1
- Low Test Results1
- No Apparent Adverse Event1
- Non Reproducible Results1
Patient problems
- No Clinical Signs, Symptoms or Conditions2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionApr 21, 2026Incorrect Measurement; Low Test Results; Non Reproducible Results
THERE WAS AN ALLEGATION OF A QUESTIONABLE ONLINE TDM METHOTREXATE RESULT FROM THE COBAS 6000 C (501) MODULE FOR ONE PATIENT. THE INITIAL RESULT WAS 1.215 UMOL/L, ACCOMPANIED BY A DATA FLAG. THE SAMPLE WAS THEN AUTO DILUTED 1:14 WITH A RESULT OF 16.012 UMOL/L. ON (B)(6) 2026 THE SAMPLE WAS REPEATED MULTIPLE TIMES. THE FIRST RESULT WAS 1.278 UMOL/L, ACCOMPANIED BY A DATA FLAG. THE AUTO-DILUTED RESULT WAS 17.548 UMOL/L, ACCOMPANIED BY A DATA FLAG. THE SAMPLE WAS DILUTED 1:50 WITH RESULTS OF 62.494 UMOL/L AND 62.643 UMOL/L, BOTH ACCOMPANIED BY A DATA FLAG. THE SAMPLE WAS DILUTED 1:200 WITH RESULTS OF 1.273 UMOL/L, ACCOMPANIED BY A DATA FLAG AND 3.627 UMOL/L. ANOTHER REPEAT RESULT AFTER A DILUTION OF 1:200 WAS 725.4 UMOL/L. THE DOCTOR WAS EXPECTING A RESULT OF >600 UMOL/L AND ASKED FOR THE SAMPLE TO BE REPEATED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24936944 ↗MalfunctionApr 3, 2024High Test Results; No Apparent Adverse Event; High Test Results; No Apparent Adverse Event
THERE WAS AN ALLEGATION OF QUESTIONABLE METHOTREXATE (MTX) RESULTS FROM THE COBAS 8000 COBAS C 502 MODULE. THE INITIAL TEST GAVE NO NUMERIC RESULT BUT HAD A DATA FLAG INDICATING THE RESULT WAS GREATER THAN THE TEST RANGE. THE REPEAT RESULT WITH A 1:10 DILUTION GAVE NO NUMERIC RESULT BUT HAD A DATA FLAG INDICATING THE RESULT WAS GREATER THAN THE TEST RANGE. THE CUSTOMER REPEATED THE SAMPLE WITH A 1:100 MANUAL DILUTION AND THE RESULT WAS 218 UMOL/L. THE NEAT SAMPLE AND THE 1:10 DILUTION SAMPLE WERE TESTED ON ANOTHER ANALYZER AND GAVE NO NUMERIC RESULT BUT HAD A DATA FLAG INDICATING THE RESULT WAS GREATER THAN THE TEST RANGE. ON THE OTHER ANALYZER, THE CUSTOMER REPEATED THE SAMPLE WITH A 1:100 MANUAL DILUTION AND THE RESULT WAS 110 UMOL/L. THE QUESTIONABLE RESULTS WERE NOT REPORTED OUTSIDE OF THE LABORATORY. THE REPEAT RESULT WAS BELIEVED CORRECT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 19032525 ↗
Other Enzyme immunoassay, methotrexate devices
- ONLINE TDM Methotrexate 09230815190Roche Diagnostics GmbH · Enzyme immunoassay, methotrexate4 reports
- ABBOTT 7A12-60Abbott Laboratories · Enzyme immunoassay, methotrexate1 report
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page